nodes	percent_of_prediction	percent_of_DWPC	metapath
Dexmethylphenidate—Vasculitis necrotising—Furosemide—dilated cardiomyopathy	0.0351	0.0365	CcSEcCtD
Dexmethylphenidate—Hexylcaine—SCN5A—dilated cardiomyopathy	0.0246	0.686	CrCbGaD
Dexmethylphenidate—Drug eruption—Spironolactone—dilated cardiomyopathy	0.022	0.0228	CcSEcCtD
Dexmethylphenidate—Ulcer—Spironolactone—dilated cardiomyopathy	0.0143	0.0148	CcSEcCtD
Dexmethylphenidate—Vasculitis—Spironolactone—dilated cardiomyopathy	0.0139	0.0144	CcSEcCtD
Dexmethylphenidate—Local reaction—Furosemide—dilated cardiomyopathy	0.0133	0.0138	CcSEcCtD
Dexmethylphenidate—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0124	0.0129	CcSEcCtD
Dexmethylphenidate—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0121	0.0126	CcSEcCtD
Dexmethylphenidate—Eruption—Furosemide—dilated cardiomyopathy	0.012	0.0124	CcSEcCtD
Dexmethylphenidate—Drug eruption—Furosemide—dilated cardiomyopathy	0.012	0.0124	CcSEcCtD
Dexmethylphenidate—Ipratropium bromide—SLC22A5—dilated cardiomyopathy	0.0112	0.314	CrCbGaD
Dexmethylphenidate—Appetite absent—Lisinopril—dilated cardiomyopathy	0.0111	0.0115	CcSEcCtD
Dexmethylphenidate—Apathy—Furosemide—dilated cardiomyopathy	0.0103	0.0107	CcSEcCtD
Dexmethylphenidate—Ear disorder—Lisinopril—dilated cardiomyopathy	0.0102	0.0106	CcSEcCtD
Dexmethylphenidate—Flat affect—Furosemide—dilated cardiomyopathy	0.0102	0.0106	CcSEcCtD
Dexmethylphenidate—Lethargy—Spironolactone—dilated cardiomyopathy	0.01	0.0104	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Spironolactone—dilated cardiomyopathy	0.00885	0.00918	CcSEcCtD
Dexmethylphenidate—Psoriasis—Lisinopril—dilated cardiomyopathy	0.00879	0.00912	CcSEcCtD
Dexmethylphenidate—Gastritis—Spironolactone—dilated cardiomyopathy	0.0087	0.00902	CcSEcCtD
Dexmethylphenidate—Drug interaction—Furosemide—dilated cardiomyopathy	0.00794	0.00823	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Spironolactone—dilated cardiomyopathy	0.00782	0.00811	CcSEcCtD
Dexmethylphenidate—Throat sore—Lisinopril—dilated cardiomyopathy	0.00767	0.00795	CcSEcCtD
Dexmethylphenidate—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00767	0.00795	CcSEcCtD
Dexmethylphenidate—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0076	0.00788	CcSEcCtD
Dexmethylphenidate—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00757	0.00785	CcSEcCtD
Dexmethylphenidate—Vasculitis—Furosemide—dilated cardiomyopathy	0.00755	0.00783	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.00751	0.00779	CcSEcCtD
Dexmethylphenidate—Otitis media—Lisinopril—dilated cardiomyopathy	0.0071	0.00736	CcSEcCtD
Dexmethylphenidate—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00691	0.00717	CcSEcCtD
Dexmethylphenidate—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00677	0.00702	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00643	0.00667	CcSEcCtD
Dexmethylphenidate—Mental disability—Furosemide—dilated cardiomyopathy	0.00639	0.00663	CcSEcCtD
Dexmethylphenidate—Accidental injury—Lisinopril—dilated cardiomyopathy	0.00625	0.00648	CcSEcCtD
Dexmethylphenidate—Chest discomfort—Lisinopril—dilated cardiomyopathy	0.00625	0.00648	CcSEcCtD
Dexmethylphenidate—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00615	0.00637	CcSEcCtD
Dexmethylphenidate—Ventricular extrasystoles—Lisinopril—dilated cardiomyopathy	0.00612	0.00635	CcSEcCtD
Dexmethylphenidate—Photosensitivity—Furosemide—dilated cardiomyopathy	0.00609	0.00631	CcSEcCtD
Dexmethylphenidate—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00608	0.0063	CcSEcCtD
Dexmethylphenidate—Swelling—Furosemide—dilated cardiomyopathy	0.00606	0.00629	CcSEcCtD
Dexmethylphenidate—Cough increased—Lisinopril—dilated cardiomyopathy	0.00604	0.00626	CcSEcCtD
Dexmethylphenidate—Alopecia—Spironolactone—dilated cardiomyopathy	0.00601	0.00623	CcSEcCtD
Dexmethylphenidate—Drug interaction—Lisinopril—dilated cardiomyopathy	0.00596	0.00618	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00569	0.0059	CcSEcCtD
Dexmethylphenidate—Dermatitis exfoliative—Furosemide—dilated cardiomyopathy	0.00567	0.00588	CcSEcCtD
Dexmethylphenidate—Vasculitis—Lisinopril—dilated cardiomyopathy	0.00566	0.00587	CcSEcCtD
Dexmethylphenidate—Thirst—Furosemide—dilated cardiomyopathy	0.00562	0.00583	CcSEcCtD
Dexmethylphenidate—Neck pain—Lisinopril—dilated cardiomyopathy	0.00559	0.0058	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00549	0.00569	CcSEcCtD
Dexmethylphenidate—Lethargy—Furosemide—dilated cardiomyopathy	0.00546	0.00566	CcSEcCtD
Dexmethylphenidate—Malaise—Spironolactone—dilated cardiomyopathy	0.00534	0.00553	CcSEcCtD
Dexmethylphenidate—Leukopenia—Spironolactone—dilated cardiomyopathy	0.0053	0.00549	CcSEcCtD
Dexmethylphenidate—Irritability—Furosemide—dilated cardiomyopathy	0.0051	0.00529	CcSEcCtD
Dexmethylphenidate—Discomfort—Spironolactone—dilated cardiomyopathy	0.00498	0.00516	CcSEcCtD
Dexmethylphenidate—Dehydration—Furosemide—dilated cardiomyopathy	0.00497	0.00516	CcSEcCtD
Dexmethylphenidate—Confusional state—Spironolactone—dilated cardiomyopathy	0.00487	0.00505	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00483	0.00501	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Furosemide—dilated cardiomyopathy	0.00481	0.00499	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00473	0.0049	CcSEcCtD
Dexmethylphenidate—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00463	0.00481	CcSEcCtD
Dexmethylphenidate—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.00461	0.00478	CcSEcCtD
Dexmethylphenidate—Hepatic function abnormal—Lisinopril—dilated cardiomyopathy	0.00459	0.00476	CcSEcCtD
Dexmethylphenidate—Photosensitivity—Lisinopril—dilated cardiomyopathy	0.00457	0.00474	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00453	0.0047	CcSEcCtD
Dexmethylphenidate—Gastroenteritis—Lisinopril—dilated cardiomyopathy	0.00453	0.00469	CcSEcCtD
Dexmethylphenidate—Eczema—Lisinopril—dilated cardiomyopathy	0.00446	0.00463	CcSEcCtD
Dexmethylphenidate—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.0044	0.00457	CcSEcCtD
Dexmethylphenidate—Injury—Lisinopril—dilated cardiomyopathy	0.00436	0.00453	CcSEcCtD
Dexmethylphenidate—Libido decreased—Lisinopril—dilated cardiomyopathy	0.00433	0.00449	CcSEcCtD
Dexmethylphenidate—Somnolence—Spironolactone—dilated cardiomyopathy	0.00429	0.00445	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Furosemide—dilated cardiomyopathy	0.00422	0.00437	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00417	0.00432	CcSEcCtD
Dexmethylphenidate—Drowsiness—Furosemide—dilated cardiomyopathy	0.00412	0.00427	CcSEcCtD
Dexmethylphenidate—Hypoglycaemia—Lisinopril—dilated cardiomyopathy	0.00411	0.00426	CcSEcCtD
Dexmethylphenidate—Cerebrovascular accident—Lisinopril—dilated cardiomyopathy	0.00409	0.00425	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.00408	0.00424	CcSEcCtD
Dexmethylphenidate—Diplopia—Lisinopril—dilated cardiomyopathy	0.00401	0.00416	CcSEcCtD
Dexmethylphenidate—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.00401	0.00416	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00398	0.00413	CcSEcCtD
Dexmethylphenidate—Disturbance in sexual arousal—Lisinopril—dilated cardiomyopathy	0.00398	0.00413	CcSEcCtD
Dexmethylphenidate—Sweating—Furosemide—dilated cardiomyopathy	0.00395	0.0041	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.0039	0.00404	CcSEcCtD
Dexmethylphenidate—Urticaria—Spironolactone—dilated cardiomyopathy	0.00384	0.00398	CcSEcCtD
Dexmethylphenidate—Irritability—Lisinopril—dilated cardiomyopathy	0.00383	0.00397	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00382	0.00396	CcSEcCtD
Dexmethylphenidate—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00381	0.00396	CcSEcCtD
Dexmethylphenidate—Dehydration—Lisinopril—dilated cardiomyopathy	0.00373	0.00387	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00365	0.00379	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00363	0.00376	CcSEcCtD
Dexmethylphenidate—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00362	0.00376	CcSEcCtD
Dexmethylphenidate—Cramp muscle—Lisinopril—dilated cardiomyopathy	0.00361	0.00375	CcSEcCtD
Dexmethylphenidate—Nasopharyngitis—Lisinopril—dilated cardiomyopathy	0.00359	0.00372	CcSEcCtD
Dexmethylphenidate—Visual impairment—Furosemide—dilated cardiomyopathy	0.00356	0.0037	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00356	0.00369	CcSEcCtD
Dexmethylphenidate—Gastritis—Lisinopril—dilated cardiomyopathy	0.00355	0.00368	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.0035	0.00363	CcSEcCtD
Dexmethylphenidate—Asthma—Lisinopril—dilated cardiomyopathy	0.00347	0.0036	CcSEcCtD
Dexmethylphenidate—Influenza—Lisinopril—dilated cardiomyopathy	0.00347	0.0036	CcSEcCtD
Dexmethylphenidate—Eye disorder—Furosemide—dilated cardiomyopathy	0.00346	0.00358	CcSEcCtD
Dexmethylphenidate—Pruritus—Spironolactone—dilated cardiomyopathy	0.00342	0.00354	CcSEcCtD
Dexmethylphenidate—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.0034	0.00353	CcSEcCtD
Dexmethylphenidate—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00338	0.0035	CcSEcCtD
Dexmethylphenidate—Angiopathy—Furosemide—dilated cardiomyopathy	0.00336	0.00348	CcSEcCtD
Dexmethylphenidate—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00334	0.00346	CcSEcCtD
Dexmethylphenidate—Bronchitis—Lisinopril—dilated cardiomyopathy	0.00333	0.00346	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0033	0.00343	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Furosemide—dilated cardiomyopathy	0.0033	0.00343	CcSEcCtD
Dexmethylphenidate—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00329	0.00341	CcSEcCtD
Dexmethylphenidate—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00322	0.00334	CcSEcCtD
Dexmethylphenidate—Malnutrition—Furosemide—dilated cardiomyopathy	0.00322	0.00334	CcSEcCtD
Dexmethylphenidate—Erythema—Furosemide—dilated cardiomyopathy	0.00322	0.00334	CcSEcCtD
Dexmethylphenidate—Dizziness—Spironolactone—dilated cardiomyopathy	0.00319	0.00331	CcSEcCtD
Dexmethylphenidate—Erectile dysfunction—Lisinopril—dilated cardiomyopathy	0.00319	0.00331	CcSEcCtD
Dexmethylphenidate—Photosensitivity reaction—Lisinopril—dilated cardiomyopathy	0.00316	0.00328	CcSEcCtD
Dexmethylphenidate—Weight increased—Lisinopril—dilated cardiomyopathy	0.00316	0.00327	CcSEcCtD
Dexmethylphenidate—Weight decreased—Lisinopril—dilated cardiomyopathy	0.00314	0.00325	CcSEcCtD
Dexmethylphenidate—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00311	0.00322	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Furosemide—dilated cardiomyopathy	0.0031	0.00321	CcSEcCtD
Dexmethylphenidate—Depression—Lisinopril—dilated cardiomyopathy	0.00308	0.0032	CcSEcCtD
Dexmethylphenidate—Vomiting—Spironolactone—dilated cardiomyopathy	0.00307	0.00318	CcSEcCtD
Dexmethylphenidate—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00306	0.00318	CcSEcCtD
Dexmethylphenidate—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00305	0.00316	CcSEcCtD
Dexmethylphenidate—Rash—Spironolactone—dilated cardiomyopathy	0.00305	0.00316	CcSEcCtD
Dexmethylphenidate—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00304	0.00316	CcSEcCtD
Dexmethylphenidate—Vision blurred—Furosemide—dilated cardiomyopathy	0.00303	0.00315	CcSEcCtD
Dexmethylphenidate—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.00303	0.00314	CcSEcCtD
Dexmethylphenidate—Headache—Spironolactone—dilated cardiomyopathy	0.00303	0.00314	CcSEcCtD
Dexmethylphenidate—Anaemia—Furosemide—dilated cardiomyopathy	0.00298	0.00309	CcSEcCtD
Dexmethylphenidate—Sweating—Lisinopril—dilated cardiomyopathy	0.00296	0.00307	CcSEcCtD
Dexmethylphenidate—Agitation—Furosemide—dilated cardiomyopathy	0.00296	0.00307	CcSEcCtD
Dexmethylphenidate—Haematuria—Lisinopril—dilated cardiomyopathy	0.00295	0.00306	CcSEcCtD
Dexmethylphenidate—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00292	0.00303	CcSEcCtD
Dexmethylphenidate—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00292	0.00302	CcSEcCtD
Dexmethylphenidate—Sinusitis—Lisinopril—dilated cardiomyopathy	0.0029	0.00301	CcSEcCtD
Dexmethylphenidate—Vertigo—Furosemide—dilated cardiomyopathy	0.00289	0.003	CcSEcCtD
Dexmethylphenidate—Leukopenia—Furosemide—dilated cardiomyopathy	0.00288	0.00299	CcSEcCtD
Dexmethylphenidate—Nausea—Spironolactone—dilated cardiomyopathy	0.00287	0.00298	CcSEcCtD
Dexmethylphenidate—Bradycardia—Lisinopril—dilated cardiomyopathy	0.00283	0.00293	CcSEcCtD
Dexmethylphenidate—Rhinitis—Lisinopril—dilated cardiomyopathy	0.00278	0.00289	CcSEcCtD
Dexmethylphenidate—Hallucination—Lisinopril—dilated cardiomyopathy	0.00276	0.00286	CcSEcCtD
Dexmethylphenidate—Pharyngitis—Lisinopril—dilated cardiomyopathy	0.00275	0.00286	CcSEcCtD
Dexmethylphenidate—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00274	0.00284	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00272	0.00282	CcSEcCtD
Dexmethylphenidate—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00272	0.00282	CcSEcCtD
Dexmethylphenidate—Dry mouth—Furosemide—dilated cardiomyopathy	0.00268	0.00278	CcSEcCtD
Dexmethylphenidate—Confusional state—Furosemide—dilated cardiomyopathy	0.00265	0.00275	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00263	0.00273	CcSEcCtD
Dexmethylphenidate—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00262	0.00272	CcSEcCtD
Dexmethylphenidate—Shock—Furosemide—dilated cardiomyopathy	0.00259	0.00268	CcSEcCtD
Dexmethylphenidate—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00258	0.00267	CcSEcCtD
Dexmethylphenidate—Flushing—Lisinopril—dilated cardiomyopathy	0.00258	0.00267	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00257	0.00267	CcSEcCtD
Dexmethylphenidate—Skin disorder—Furosemide—dilated cardiomyopathy	0.00255	0.00265	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00254	0.00263	CcSEcCtD
Dexmethylphenidate—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00252	0.00261	CcSEcCtD
Dexmethylphenidate—Anorexia—Furosemide—dilated cardiomyopathy	0.0025	0.0026	CcSEcCtD
Dexmethylphenidate—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.0025	0.00259	CcSEcCtD
Dexmethylphenidate—Chills—Lisinopril—dilated cardiomyopathy	0.00249	0.00258	CcSEcCtD
Dexmethylphenidate—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00248	0.00257	CcSEcCtD
Dexmethylphenidate—Alopecia—Lisinopril—dilated cardiomyopathy	0.00245	0.00254	CcSEcCtD
Dexmethylphenidate—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00243	0.00252	CcSEcCtD
Dexmethylphenidate—Erythema—Lisinopril—dilated cardiomyopathy	0.00242	0.00251	CcSEcCtD
Dexmethylphenidate—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00242	0.00251	CcSEcCtD
Dexmethylphenidate—Tension—Lisinopril—dilated cardiomyopathy	0.00237	0.00246	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00236	0.00245	CcSEcCtD
Dexmethylphenidate—Nervousness—Lisinopril—dilated cardiomyopathy	0.00235	0.00243	CcSEcCtD
Dexmethylphenidate—Back pain—Lisinopril—dilated cardiomyopathy	0.00234	0.00242	CcSEcCtD
Dexmethylphenidate—Somnolence—Furosemide—dilated cardiomyopathy	0.00234	0.00242	CcSEcCtD
Dexmethylphenidate—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00232	0.00241	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00228	0.00237	CcSEcCtD
Dexmethylphenidate—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00228	0.00236	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00227	0.00235	CcSEcCtD
Dexmethylphenidate—Fatigue—Furosemide—dilated cardiomyopathy	0.00227	0.00235	CcSEcCtD
Dexmethylphenidate—Tremor—Lisinopril—dilated cardiomyopathy	0.00226	0.00235	CcSEcCtD
Dexmethylphenidate—Constipation—Furosemide—dilated cardiomyopathy	0.00225	0.00233	CcSEcCtD
Dexmethylphenidate—Pain—Furosemide—dilated cardiomyopathy	0.00225	0.00233	CcSEcCtD
Dexmethylphenidate—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00224	0.00232	CcSEcCtD
Dexmethylphenidate—Anaemia—Lisinopril—dilated cardiomyopathy	0.00223	0.00232	CcSEcCtD
Dexmethylphenidate—Angioedema—Lisinopril—dilated cardiomyopathy	0.00221	0.00229	CcSEcCtD
Dexmethylphenidate—Malaise—Lisinopril—dilated cardiomyopathy	0.00218	0.00226	CcSEcCtD
Dexmethylphenidate—Vertigo—Lisinopril—dilated cardiomyopathy	0.00217	0.00225	CcSEcCtD
Dexmethylphenidate—Syncope—Lisinopril—dilated cardiomyopathy	0.00217	0.00225	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00217	0.00225	CcSEcCtD
Dexmethylphenidate—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00216	0.00224	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00215	0.00223	CcSEcCtD
Dexmethylphenidate—Palpitations—Lisinopril—dilated cardiomyopathy	0.00213	0.00221	CcSEcCtD
Dexmethylphenidate—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00212	0.0022	CcSEcCtD
Dexmethylphenidate—Cough—Lisinopril—dilated cardiomyopathy	0.00211	0.00219	CcSEcCtD
Dexmethylphenidate—Urticaria—Furosemide—dilated cardiomyopathy	0.00209	0.00216	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00208	0.00215	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00208	0.00215	CcSEcCtD
Dexmethylphenidate—Chest pain—Lisinopril—dilated cardiomyopathy	0.00206	0.00213	CcSEcCtD
Dexmethylphenidate—Myalgia—Lisinopril—dilated cardiomyopathy	0.00206	0.00213	CcSEcCtD
Dexmethylphenidate—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00206	0.00213	CcSEcCtD
Dexmethylphenidate—Anxiety—Lisinopril—dilated cardiomyopathy	0.00205	0.00213	CcSEcCtD
Dexmethylphenidate—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00204	0.00212	CcSEcCtD
Dexmethylphenidate—Discomfort—Lisinopril—dilated cardiomyopathy	0.00203	0.00211	CcSEcCtD
Dexmethylphenidate—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00201	0.00209	CcSEcCtD
Dexmethylphenidate—Confusional state—Lisinopril—dilated cardiomyopathy	0.00199	0.00206	CcSEcCtD
Dexmethylphenidate—Oedema—Lisinopril—dilated cardiomyopathy	0.00197	0.00204	CcSEcCtD
Dexmethylphenidate—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00197	0.00204	CcSEcCtD
Dexmethylphenidate—Infection—Lisinopril—dilated cardiomyopathy	0.00196	0.00203	CcSEcCtD
Dexmethylphenidate—Shock—Lisinopril—dilated cardiomyopathy	0.00194	0.00201	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00194	0.00201	CcSEcCtD
Dexmethylphenidate—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00193	0.002	CcSEcCtD
Dexmethylphenidate—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00192	0.002	CcSEcCtD
Dexmethylphenidate—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00192	0.00199	CcSEcCtD
Dexmethylphenidate—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00191	0.00198	CcSEcCtD
Dexmethylphenidate—Asthenia—Furosemide—dilated cardiomyopathy	0.00189	0.00196	CcSEcCtD
Dexmethylphenidate—Anorexia—Lisinopril—dilated cardiomyopathy	0.00188	0.00195	CcSEcCtD
Dexmethylphenidate—Pruritus—Furosemide—dilated cardiomyopathy	0.00186	0.00193	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Furosemide—dilated cardiomyopathy	0.0018	0.00186	CcSEcCtD
Dexmethylphenidate—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.0018	0.00186	CcSEcCtD
Dexmethylphenidate—Insomnia—Lisinopril—dilated cardiomyopathy	0.00178	0.00185	CcSEcCtD
Dexmethylphenidate—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00177	0.00184	CcSEcCtD
Dexmethylphenidate—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00176	0.00182	CcSEcCtD
Dexmethylphenidate—Somnolence—Lisinopril—dilated cardiomyopathy	0.00175	0.00182	CcSEcCtD
Dexmethylphenidate—Dizziness—Furosemide—dilated cardiomyopathy	0.00174	0.0018	CcSEcCtD
Dexmethylphenidate—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00174	0.0018	CcSEcCtD
Dexmethylphenidate—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.00171	0.00178	CcSEcCtD
Dexmethylphenidate—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00177	CcSEcCtD
Dexmethylphenidate—Fatigue—Lisinopril—dilated cardiomyopathy	0.0017	0.00176	CcSEcCtD
Dexmethylphenidate—Pain—Lisinopril—dilated cardiomyopathy	0.00169	0.00175	CcSEcCtD
Dexmethylphenidate—Constipation—Lisinopril—dilated cardiomyopathy	0.00169	0.00175	CcSEcCtD
Dexmethylphenidate—Vomiting—Furosemide—dilated cardiomyopathy	0.00167	0.00173	CcSEcCtD
Dexmethylphenidate—Rash—Furosemide—dilated cardiomyopathy	0.00166	0.00172	CcSEcCtD
Dexmethylphenidate—Dermatitis—Furosemide—dilated cardiomyopathy	0.00166	0.00172	CcSEcCtD
Dexmethylphenidate—Headache—Furosemide—dilated cardiomyopathy	0.00165	0.00171	CcSEcCtD
Dexmethylphenidate—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00162	0.00168	CcSEcCtD
Dexmethylphenidate—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00161	0.00167	CcSEcCtD
Dexmethylphenidate—Urticaria—Lisinopril—dilated cardiomyopathy	0.00157	0.00162	CcSEcCtD
Dexmethylphenidate—Nausea—Furosemide—dilated cardiomyopathy	0.00156	0.00162	CcSEcCtD
Dexmethylphenidate—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00156	0.00162	CcSEcCtD
Dexmethylphenidate—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00156	0.00162	CcSEcCtD
Dexmethylphenidate—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00145	0.00151	CcSEcCtD
Dexmethylphenidate—Asthenia—Lisinopril—dilated cardiomyopathy	0.00141	0.00147	CcSEcCtD
Dexmethylphenidate—Pruritus—Lisinopril—dilated cardiomyopathy	0.00139	0.00145	CcSEcCtD
Dexmethylphenidate—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00135	0.0014	CcSEcCtD
Dexmethylphenidate—Dizziness—Lisinopril—dilated cardiomyopathy	0.0013	0.00135	CcSEcCtD
Dexmethylphenidate—Vomiting—Lisinopril—dilated cardiomyopathy	0.00125	0.0013	CcSEcCtD
Dexmethylphenidate—Rash—Lisinopril—dilated cardiomyopathy	0.00124	0.00129	CcSEcCtD
Dexmethylphenidate—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00124	0.00129	CcSEcCtD
Dexmethylphenidate—Headache—Lisinopril—dilated cardiomyopathy	0.00124	0.00128	CcSEcCtD
Dexmethylphenidate—Nausea—Lisinopril—dilated cardiomyopathy	0.00117	0.00121	CcSEcCtD
